Only 100 million shares in issue, 6.25p to buy at present. I own these shares and expect this share to reach between 12-16p by september. it is very good value at present to buy.

The company expects to announce its interim results for the six months ended 30
June 2006 in September.

Based on unaudited information the directors expect core revenues, being the
supply of tissue samples and derivatives and the provision of drug discovery
services, to be not less than 3.7 million. In addition, revenues of 350,000
have been received relating to the licensing of the R4 programme.


At 30 June 2006 the company had cash resources of 6.2 million.


Furthermore, Asterand PLC said it is to offer drug discovery services to the Japanese market through a deal with Mitsui Corporation and Toyobo Co Ltd.

The human tissue research company said it will supply Japanese drug discovery companies with biological samples, data and research services covering a range of diseases, including cancer, gastrointestinal, respiratory, metabolic disorders, inflammatory, cardiovascular, as well as diseases of the Central Nervous System such as Alzheimer's.

this is a good one to Buy and stock as many as you can at these levels. However as usual DO YOUR OWN RESEARCH.

Hi peeyam,
Have these on my watch list.Do you know the reason for the recent sp drop?50% in a month.

Peeyam, what is the R4 programme?

It would be nice to think that the only way is up for this stock, especially seeing the height from which it has fallen. However, I'd be concerned about dilution as they will doubtless need to raise new funds via a placing in order to stay in business. Any views?

Notification of Interim Results



13 September 2006 - Asterand plc (LSE: ATD), the human tissue research services
company, today announces that it will report its interim results for the six
months ended 30 June 2006 on Monday 25 September 2006.

good luck to all shareholders

Poster-Interest has hit the floor during 07/08, - - - until some good-ish news created a rush....now it's slipping back, as it's obvious this is a L-T business and you might as well take the profit. Take care this likes the 5p floor area.
I'm waiting for sub-6p

New article, click HERE

ATD, BII, and SEE, are presenting in London 11th March!

Good opportunity to watch the latest presentation, then meet the management informally, over canap and wine'

This is a first class hotel, registration is free, as are the post presentation refreshments!


To register, click HERE


5 minutes walk from Green Park tube, 10 minutes from Bond Street.

Early registration is advised.

Guys : this is one that deserves more following than it's getting....nice rise and I would like to think this is about to jump !.

New article, click HERE

This is a FREE event

Proactive Investors One2One Forums

The directors of Rexahn Pharmaceuticals (AMEX: RNN), Asterand (LSE: ATD), Alliance Pharma plc (AIM: APH) and EpiStem Holdings Plc (AIM: EHP) will be presenting:

Tuesday the 20th April 2010 - Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:
Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.


Register Here - http://www.sign-up.to/signup.php?fid=2015&pid=7163

If you have any problems registering or queries please email action@proactiveinvestors.com

These are superb evenings set in a wonderful environment, and afford the rare opportunity for the private investor to meet the CEO's in an informal setting.


Nearest tube stations are Green Park and Bond Street.

New article, click HERE

No news that I can see (unless broker note)...but this has shot up at long last....

The directors of Lo-Q (AIM: LOQ), e-Therapeutics plc (AIM: ETX), Asterand (LSE: ATD) and Norcon Plc (AIM: NCON) will be presenting:
Thursday the 3rd March 2011, Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8.00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:
Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

FREE registration - http://www.proactiveinvestors.co.uk/register/event_details/102

If you have any problems registering or queries please email events@proactiveinvestors.com.au.